FBDD Fragments Base Drugs Discovery | Design
Login |
 Shopping Cart
 
Items : (0) Total: $ 0.00

               
Search    
21-Dec-2007
  IOTA announces FBDD screening services
   
21-Dec-2007
  IOTA announces collaboration with Vitas M-laboratory and new FBDD library:IOTA-Vitas 4000
   
25-Sep-2007
  IOTA Pharmaceuticals established; research centers in the UK, the Netherlands, and India.
   
25-Sep-2007
  IOTA announces FBDD Initiative with the VU University, Amsterdam
   
25-Sep-2007
  IOTA announces first FBDD product: IOTA Diverse 1500
   
 
 
IOTA’s Business Development offices are based in the St Johns Innovation Centre in Cambridge, Europe’s leading biotech city. Web-focussed, we offer business connectivity in the fragment-based drug design area to drug discovery companies, large and small.
 
Led by IOTA co-Founder Dr David Bailey, the business team has extensive experience working with large and small pharma, as well as international biotech companies.
 
 
IOTA Business
On-line LibrariesIOTA DesignIOTA Discovery
IOTA ScreeningIOTA ChemistryIOTA Services
Copyright © 2007 IOTA Pharmaceuticals